Have your own idea? Try our Stock Screener
Mexican (IPC) Healthcare Sector Analysis
UpdatedApr 29, 2026
DataAggregated Company Financials
Companies2
- 7D-8.8%
- 3M0.8%
- 1Y-14.6%
- YTD-5.8%
Over the last 7 days, the Healthcare industry has dropped 8.8%, driven by pullbacks from every company within the industry. The industry has fallen 15% in the last year. As for the next few years, earnings are expected to grow by 15% per annum.
Sector Valuation and Performance
Has the Mexican Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 29 Apr 2026 | Mex$22.5b | Mex$22.1b | Mex$2.1b | 11.1x | 10.5x | 1x |
| Fri, 27 Mar 2026 | Mex$23.8b | Mex$22.3b | Mex$2.1b | 11.5x | 11.1x | 1.1x |
| Sun, 22 Feb 2026 | Mex$23.7b | Mex$22.9b | Mex$2.2b | 11.3x | 10.8x | 1x |
| Tue, 20 Jan 2026 | Mex$23.6b | Mex$22.9b | Mex$2.2b | 11.1x | 10.8x | 1x |
| Thu, 18 Dec 2025 | Mex$23.2b | Mex$22.9b | Mex$2.2b | 10.8x | 10.6x | 1x |
| Sat, 15 Nov 2025 | Mex$23.6b | Mex$22.9b | Mex$2.2b | 10.8x | 10.8x | 1x |
| Mon, 13 Oct 2025 | Mex$22.8b | Mex$23.5b | Mex$2.4b | 9.7x | 9.4x | 1x |
| Wed, 10 Sep 2025 | Mex$25.9b | Mex$23.5b | Mex$2.4b | 10.1x | 10.7x | 1.1x |
| Fri, 08 Aug 2025 | Mex$26.2b | Mex$23.5b | Mex$2.4b | 10.2x | 10.9x | 1.1x |
| Sun, 06 Jul 2025 | Mex$25.0b | Mex$23.3b | Mex$2.6b | 10.1x | 9.6x | 1.1x |
| Tue, 03 Jun 2025 | Mex$26.9b | Mex$23.3b | Mex$2.6b | 10.5x | 10.3x | 1.2x |
| Thu, 01 May 2025 | Mex$27.9b | Mex$23.0b | Mex$2.6b | 9.8x | 10.9x | 1.2x |
| Sat, 29 Mar 2025 | Mex$28.6b | Mex$23.0b | Mex$2.6b | 10.3x | 11.2x | 1.2x |
| Mon, 24 Feb 2025 | Mex$28.9b | Mex$21.9b | Mex$2.0b | 12.3x | 14.3x | 1.3x |
| Wed, 22 Jan 2025 | Mex$29.1b | Mex$21.8b | Mex$2.0b | 12.8x | 14.7x | 1.3x |
| Fri, 20 Dec 2024 | Mex$28.7b | Mex$21.8b | Mex$2.0b | 12.4x | 14.5x | 1.3x |
| Sun, 17 Nov 2024 | Mex$28.3b | Mex$21.8b | Mex$2.0b | 12x | 14.3x | 1.3x |
| Tue, 15 Oct 2024 | Mex$25.2b | Mex$20.9b | Mex$1.8b | 11.8x | 14.3x | 1.2x |
| Thu, 12 Sep 2024 | Mex$23.8b | Mex$20.9b | Mex$1.8b | 11.7x | 13.5x | 1.1x |
| Sat, 10 Aug 2024 | Mex$21.3b | Mex$20.9b | Mex$1.8b | 10.9x | 12.1x | 1x |
| Mon, 08 Jul 2024 | Mex$20.0b | Mex$20.6b | Mex$1.6b | 11.4x | 12.6x | 1x |
| Wed, 05 Jun 2024 | Mex$18.8b | Mex$20.6b | Mex$1.6b | 11.4x | 11.9x | 0.9x |
| Fri, 03 May 2024 | Mex$19.9b | Mex$20.6b | Mex$1.6b | 11.6x | 12.6x | 1x |
| Sun, 31 Mar 2024 | Mex$19.2b | Mex$20.6b | Mex$1.6b | 11.2x | 12.1x | 0.9x |
| Tue, 27 Feb 2024 | Mex$17.6b | Mex$20.5b | Mex$1.5b | 11.2x | 11.7x | 0.9x |
| Thu, 25 Jan 2024 | Mex$17.2b | Mex$21.1b | Mex$1.9b | 9.2x | 9.2x | 0.8x |
| Sat, 23 Dec 2023 | Mex$17.0b | Mex$21.1b | Mex$1.9b | 9.3x | 9.2x | 0.8x |
| Mon, 20 Nov 2023 | Mex$17.6b | Mex$21.1b | Mex$1.9b | 9.5x | 9.5x | 0.8x |
| Wed, 18 Oct 2023 | Mex$17.1b | Mex$21.1b | Mex$1.9b | 9.1x | 9.1x | 0.8x |
| Fri, 15 Sep 2023 | Mex$17.9b | Mex$21.1b | Mex$1.9b | 9.4x | 9.5x | 0.8x |
| Sun, 13 Aug 2023 | Mex$18.6b | Mex$21.1b | Mex$1.9b | 9.8x | 9.8x | 0.9x |
| Tue, 11 Jul 2023 | Mex$17.3b | Mex$21.0b | Mex$1.9b | 9.1x | 9.1x | 0.8x |
| Thu, 08 Jun 2023 | Mex$19.4b | Mex$21.0b | Mex$1.9b | 9.9x | 10.2x | 0.9x |
| Sat, 06 May 2023 | Mex$20.4b | Mex$21.0b | Mex$1.9b | 10.9x | 10.8x | 1x |
Price to Earnings Ratio
10.8x
Current Industry PE
- There are only 2 companies in the Mexican Healthcare industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 4.1% per year over the last three years, while revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the Mexican Healthcare sector?
| MX Market | -2.12% | |
| Healthcare | -8.81% | |
| Healthcare Services | -0.49% | |
| Pharma | -11.86% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 9.5x.
- Analysts are expecting annual earnings growth of 8.4%, which is lower than the prior year's growth of 27.9% per year.
- Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 11.8x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 18% over the next 5 years.
- This is better than its past earnings decline of 26% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 8.4% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||